Hypermethylation of CSF3R is a novel cisplatin resistance marker and predictor of response to postoperative chemotherapy in hepatoblastoma-Reference-Cited by-同舟云学术

Hypermethylation of CSF3R is a novel cisplatin resistance marker and predictor of response to postoperative chemotherapy in hepatoblastoma

Author:

Fujiyoshi Sunao¹,Honda Shohei¹,Minato Masashi¹,Ara Momoko¹,Suzuki Hiromu²,Hiyama Eiso³,Taketomi Akinobu¹

Affiliation:

1. Department of Gastroenterological Surgery 1Hokkaido University Graduate School of Medicine Sapporo Japan

2. Department of Basic Medical Science and Molecular BiologySapporo Medical University School of Medicine Sapporo Japan

3. Japan Children's Cancer Group (JCCG) liver tumor committee (JPLT) Hiroshima Japan

Funder

Akiyama Life Science Foundation

Japan Society for the Promotion of Science

Uehara Memorial Foundation

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

Reference26 articles.

5. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta‐catenin gene;Koch A;Cancer Res,1999

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

5. Epigenetic and Genetics Factors;Molecular Targets and Cancer Therapeutics (Part 1);2023-04-18